| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 1.86e-07 | 5 | 54 | 3 | GO:0052871 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 6.49e-07 | 7 | 54 | 3 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 6.49e-07 | 7 | 54 | 3 | GO:0018685 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 8.00e-07 | 27 | 54 | 4 | GO:0033038 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.84e-06 | 33 | 54 | 4 | GO:0008527 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | CELSR1 TAS2R13 DRD5 FCGR2A OR10G3 CD300LB OR4D1 MRGPRX2 TAS2R45 TAS2R31 ITGA2 TAS2R43 SUCNR1 F2RL1 IL17RB | 1.89e-06 | 1353 | 54 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 2.21e-06 | 10 | 54 | 3 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 2.21e-06 | 10 | 54 | 3 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 2.21e-06 | 10 | 54 | 3 | GO:0102033 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 5.25e-06 | 13 | 54 | 3 | GO:0016713 | |
| GeneOntologyMolecularFunction | integrin binding | 7.58e-06 | 175 | 54 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | CELSR1 TAS2R13 DRD5 OR10G3 OR4D1 MRGPRX2 TAS2R45 TAS2R31 TAS2R43 SUCNR1 F2RL1 | 2.01e-05 | 884 | 54 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 3.63e-05 | 24 | 54 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 5.22e-05 | 27 | 54 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | ribonuclease A activity | 7.14e-05 | 5 | 54 | 2 | GO:0004522 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.15e-04 | 35 | 54 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.72e-04 | 40 | 54 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 3'-phosphomonoesters | 1.99e-04 | 8 | 54 | 2 | GO:0016892 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 3.15e-04 | 49 | 54 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 3.19e-04 | 10 | 54 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | antiporter activity | 5.28e-04 | 138 | 54 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | arachidonate binding | 7.37e-04 | 15 | 54 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | heme binding | 7.97e-04 | 154 | 54 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | icosanoid binding | 8.41e-04 | 16 | 54 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 8.41e-04 | 16 | 54 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 1.01e-03 | 164 | 54 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.02e-03 | 73 | 54 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.05e-03 | 166 | 54 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.21e-03 | 296 | 54 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.30e-03 | 301 | 54 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 1.32e-03 | 20 | 54 | 2 | GO:0016894 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.58e-03 | 85 | 54 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.63e-03 | 86 | 54 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.76e-03 | 477 | 54 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | long-chain fatty acid binding | 2.59e-03 | 28 | 54 | 2 | GO:0036041 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.73e-03 | 115 | 54 | 3 | GO:0004497 | |
| GeneOntologyMolecularFunction | laminin binding | 3.81e-03 | 34 | 54 | 2 | GO:0043236 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC11A2 PSG3 ATP13A1 SLC19A1 CATSPER4 SLC9A7 DISP2 SLC44A4 SLC18B1 | 4.09e-03 | 1180 | 54 | 9 | GO:0022857 |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 4.26e-03 | 36 | 54 | 2 | GO:0090482 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 4.99e-03 | 39 | 54 | 2 | GO:0015605 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.41e-03 | 599 | 54 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 6.04e-03 | 43 | 54 | 2 | GO:0001965 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 6.31e-03 | 44 | 54 | 2 | GO:0046915 | |
| GeneOntologyMolecularFunction | transporter activity | SLC11A2 PSG3 ATP13A1 SLC19A1 CATSPER4 SLC9A7 DISP2 SLC44A4 SLC18B1 | 7.23e-03 | 1289 | 54 | 9 | GO:0005215 |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.57e-07 | 6 | 55 | 3 | GO:0036101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 6.23e-07 | 7 | 55 | 3 | GO:0036102 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 9.95e-07 | 8 | 55 | 3 | GO:0036100 | |
| GeneOntologyBiologicalProcess | icosanoid catabolic process | 2.92e-06 | 11 | 55 | 3 | GO:1901523 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid catabolic process | 3.88e-06 | 12 | 55 | 3 | GO:0042758 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 4.37e-06 | 91 | 55 | 5 | GO:0033627 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 5.67e-06 | 44 | 55 | 4 | GO:0001580 | |
| GeneOntologyBiologicalProcess | sensory perception of bitter taste | 8.07e-06 | 48 | 55 | 4 | GO:0050913 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 9.51e-06 | 50 | 55 | 4 | GO:0050912 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.98e-05 | 124 | 55 | 5 | GO:0007229 | |
| GeneOntologyBiologicalProcess | fatty acid derivative catabolic process | 2.67e-05 | 22 | 55 | 3 | GO:1901569 | |
| GeneOntologyBiologicalProcess | sensory perception of taste | 3.64e-05 | 70 | 55 | 4 | GO:0050909 | |
| GeneOntologyBiologicalProcess | wound healing | 4.57e-05 | 493 | 55 | 8 | GO:0042060 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 4.63e-05 | 148 | 55 | 5 | GO:0002444 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CELSR1 TAS2R13 DRD5 OR10G3 OR4D1 MRGPRX2 TAS2R45 TAS2R31 TAS2R43 SUCNR1 F2RL1 ITGB3 HTT | 5.85e-05 | 1395 | 55 | 13 | GO:0007186 |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of systemic arterial blood pressure | 7.65e-05 | 31 | 55 | 3 | GO:0003071 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 8.06e-05 | 270 | 55 | 6 | GO:0007160 | |
| GeneOntologyBiologicalProcess | serotonin transport | 8.42e-05 | 32 | 55 | 3 | GO:0006837 | |
| GeneOntologyBiologicalProcess | import into cell | SLC11A2 FCGR2A PSG3 SLC19A1 SLC9A7 SIGLEC1 ITGA2 F2RL1 SLC18B1 ITGB3 LYST | 1.05e-04 | 1074 | 55 | 11 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 1.65e-04 | 442 | 55 | 7 | GO:0050878 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.78e-04 | 41 | 55 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | renin secretion into blood stream | 2.48e-04 | 9 | 55 | 2 | GO:0002001 | |
| GeneOntologyBiologicalProcess | neutrophil mediated immunity | 2.85e-04 | 48 | 55 | 3 | GO:0002446 | |
| GeneOntologyBiologicalProcess | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure | 3.10e-04 | 10 | 55 | 2 | GO:0001999 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure | 3.35e-04 | 124 | 55 | 4 | GO:0003073 | |
| GeneOntologyBiologicalProcess | response to wounding | 3.36e-04 | 659 | 55 | 8 | GO:0009611 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by hormone | 3.41e-04 | 51 | 55 | 3 | GO:0001990 | |
| GeneOntologyBiologicalProcess | otolith development | 3.78e-04 | 11 | 55 | 2 | GO:0048840 | |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 4.53e-04 | 12 | 55 | 2 | GO:0071421 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 5.79e-04 | 61 | 55 | 3 | GO:0003044 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 6.16e-04 | 722 | 55 | 8 | GO:0051606 | |
| GeneOntologyBiologicalProcess | serotonin uptake | 6.22e-04 | 14 | 55 | 2 | GO:0051610 | |
| GeneOntologyBiologicalProcess | manganese ion transport | 6.22e-04 | 14 | 55 | 2 | GO:0006828 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 6.22e-04 | 14 | 55 | 2 | GO:0097267 | |
| GeneOntologyBiologicalProcess | blood coagulation | 6.37e-04 | 260 | 55 | 5 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 7.06e-04 | 266 | 55 | 5 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 7.30e-04 | 268 | 55 | 5 | GO:0007599 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 7.57e-04 | 410 | 55 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 7.95e-04 | 68 | 55 | 3 | GO:0019369 | |
| GeneOntologyBiologicalProcess | phagocytosis | 8.07e-04 | 274 | 55 | 5 | GO:0006909 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 8.30e-04 | 69 | 55 | 3 | GO:0006911 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 8.62e-04 | 582 | 55 | 7 | GO:0050906 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 9.78e-04 | 73 | 55 | 3 | GO:1901616 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis, engulfment | 1.04e-03 | 18 | 55 | 2 | GO:0060100 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane invagination | 1.04e-03 | 18 | 55 | 2 | GO:1905155 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of blood volume | 1.04e-03 | 18 | 55 | 2 | GO:0001977 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 1.07e-03 | 169 | 55 | 4 | GO:0046718 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 1.18e-03 | 78 | 55 | 3 | GO:0099024 | |
| GeneOntologyBiologicalProcess | leukocyte migration | 1.21e-03 | 449 | 55 | 6 | GO:0050900 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 1.24e-03 | 176 | 55 | 4 | GO:0044409 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.35e-03 | 180 | 55 | 4 | GO:0120254 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 1.37e-03 | 82 | 55 | 3 | GO:1901568 | |
| GeneOntologyCellularComponent | integrin complex | 2.19e-08 | 32 | 56 | 5 | GO:0008305 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 5.15e-07 | 59 | 56 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | apical part of cell | CYP4F8 SLC11A2 PSG3 SLC19A1 ITGA8 CYP4F3 CYP4F12 SLC44A4 ITGB3 | 2.55e-05 | 592 | 56 | 9 | GO:0045177 |
| GeneOntologyCellularComponent | cell surface | SLC11A2 FCGR2A PSG3 ADAM21 ITGA8 CLMP ITGA2 SUCNR1 ITGA7 ITGB3 ITGB5 IL17RB | 3.04e-05 | 1111 | 56 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | apical plasma membrane | 4.36e-05 | 487 | 56 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.46e-04 | 431 | 56 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.21e-04 | 785 | 56 | 9 | GO:0098797 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 3.39e-04 | 350 | 56 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.52e-04 | 519 | 56 | 7 | GO:0009897 | |
| GeneOntologyCellularComponent | brush border membrane | 1.44e-03 | 83 | 56 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | ciliary membrane | 2.31e-03 | 98 | 56 | 3 | GO:0060170 | |
| GeneOntologyCellularComponent | recycling endosome | 2.95e-03 | 222 | 56 | 4 | GO:0055037 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 3.38e-03 | 112 | 56 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | anchoring junction | 4.26e-03 | 976 | 56 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | receptor complex | 4.49e-03 | 581 | 56 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.57e-03 | 583 | 56 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | membrane protein complex | CDH26 PSG3 CATSPER4 ITGA8 NOX3 ITGA2 ITGA7 ITGB3 ITGB5 STX12 | 5.95e-03 | 1498 | 56 | 10 | GO:0098796 |
| GeneOntologyCellularComponent | cell-substrate junction | 6.58e-03 | 443 | 56 | 5 | GO:0030055 | |
| GeneOntologyCellularComponent | brush border | 7.88e-03 | 152 | 56 | 3 | GO:0005903 | |
| Domain | Integrin_dom | 7.72e-09 | 25 | 53 | 5 | IPR032695 | |
| Domain | TAS2R | 8.25e-07 | 26 | 53 | 4 | PF05296 | |
| Domain | T2R | 8.25e-07 | 26 | 53 | 4 | IPR007960 | |
| Domain | Integrin_alpha_C_CS | 1.18e-05 | 16 | 53 | 3 | IPR018184 | |
| Domain | Integrin_alpha-2 | 1.71e-05 | 18 | 53 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.71e-05 | 18 | 53 | 3 | PF08441 | |
| Domain | Integrin_alpha | 1.71e-05 | 18 | 53 | 3 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 1.71e-05 | 18 | 53 | 3 | PS00242 | |
| Domain | Int_alpha_beta-p | 2.02e-05 | 19 | 53 | 3 | IPR013519 | |
| Domain | Int_alpha | 2.02e-05 | 19 | 53 | 3 | SM00191 | |
| Domain | FG_GAP | 3.20e-05 | 22 | 53 | 3 | PS51470 | |
| Domain | FG-GAP | 4.19e-05 | 24 | 53 | 3 | PF01839 | |
| Domain | FG-GAP | 4.19e-05 | 24 | 53 | 3 | IPR013517 | |
| Domain | - | 4.72e-05 | 4 | 53 | 2 | 1.20.5.630 | |
| Domain | Ig_2 | 5.44e-05 | 73 | 53 | 4 | PF13895 | |
| Domain | Integrin_bsu_cyt_dom | 1.18e-04 | 6 | 53 | 2 | IPR014836 | |
| Domain | Integrin_b_cyt | 1.18e-04 | 6 | 53 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 1.18e-04 | 6 | 53 | 2 | PF08725 | |
| Domain | Integrin_bsu_tail | 1.64e-04 | 7 | 53 | 2 | IPR012896 | |
| Domain | Integrin_B_tail | 1.64e-04 | 7 | 53 | 2 | SM01242 | |
| Domain | Integrin_B_tail | 1.64e-04 | 7 | 53 | 2 | PF07965 | |
| Domain | RNaseA_AS | 2.19e-04 | 8 | 53 | 2 | IPR023411 | |
| Domain | INB | 2.19e-04 | 8 | 53 | 2 | SM00187 | |
| Domain | Integrin_beta | 2.19e-04 | 8 | 53 | 2 | PF00362 | |
| Domain | Integrin_bsu_VWA | 2.19e-04 | 8 | 53 | 2 | IPR002369 | |
| Domain | RNASE_PANCREATIC | 2.19e-04 | 8 | 53 | 2 | PS00127 | |
| Domain | Integrin_bsu | 2.81e-04 | 9 | 53 | 2 | IPR015812 | |
| Domain | INTEGRIN_BETA | 2.81e-04 | 9 | 53 | 2 | PS00243 | |
| Domain | PSI_integrin | 2.81e-04 | 9 | 53 | 2 | PF17205 | |
| Domain | Integin_beta_N | 2.81e-04 | 9 | 53 | 2 | IPR033760 | |
| Domain | Cyt_P450_E_grp-I | 2.81e-04 | 45 | 53 | 3 | IPR002401 | |
| Domain | RNAse_Pc | 4.27e-04 | 11 | 53 | 2 | SM00092 | |
| Domain | Integrin_alpha | 4.27e-04 | 11 | 53 | 2 | PF00357 | |
| Domain | Cyt_P450_CS | 4.57e-04 | 53 | 53 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 5.67e-04 | 57 | 53 | 3 | PS00086 | |
| Domain | - | 5.96e-04 | 58 | 53 | 3 | 1.10.630.10 | |
| Domain | p450 | 5.96e-04 | 58 | 53 | 3 | PF00067 | |
| Domain | RNaseA | 6.04e-04 | 13 | 53 | 2 | PD000535 | |
| Domain | Cyt_P450 | 6.59e-04 | 60 | 53 | 3 | IPR001128 | |
| Domain | RnaseA | 8.10e-04 | 15 | 53 | 2 | PF00074 | |
| Domain | RNaseA | 8.10e-04 | 15 | 53 | 2 | IPR001427 | |
| Domain | RNaseA_domain | 8.10e-04 | 15 | 53 | 2 | IPR023412 | |
| Domain | - | 8.10e-04 | 15 | 53 | 2 | 3.10.130.10 | |
| Domain | VWFA | 1.63e-03 | 82 | 53 | 3 | PS50234 | |
| Domain | VWA | 1.75e-03 | 84 | 53 | 3 | SM00327 | |
| Domain | V-set | 1.83e-03 | 184 | 53 | 4 | PF07686 | |
| Domain | Ig_V-set | 2.44e-03 | 199 | 53 | 4 | IPR013106 | |
| Domain | VWF_A | 2.79e-03 | 99 | 53 | 3 | IPR002035 | |
| Domain | IGc2 | 4.42e-03 | 235 | 53 | 4 | SM00408 | |
| Domain | Ig_sub2 | 4.42e-03 | 235 | 53 | 4 | IPR003598 | |
| Domain | EGF | 5.49e-03 | 126 | 53 | 3 | PF00008 | |
| Domain | EGF_1 | 5.88e-03 | 255 | 53 | 4 | PS00022 | |
| Domain | EGF-like_CS | 6.38e-03 | 261 | 53 | 4 | IPR013032 | |
| Domain | IG | 6.71e-03 | 421 | 53 | 5 | SM00409 | |
| Domain | Ig_sub | 6.71e-03 | 421 | 53 | 5 | IPR003599 | |
| Domain | EGF_2 | 6.73e-03 | 265 | 53 | 4 | PS01186 | |
| Domain | PSI | 6.93e-03 | 44 | 53 | 2 | IPR016201 | |
| Domain | PSI | 7.55e-03 | 46 | 53 | 2 | SM00423 | |
| Domain | GPCR_Rhodpsn_7TM | 1.14e-02 | 670 | 53 | 6 | IPR017452 | |
| Domain | 7tm_1 | 1.20e-02 | 677 | 53 | 6 | PF00001 | |
| Domain | IG_LIKE | 1.25e-02 | 491 | 53 | 5 | PS50835 | |
| Domain | EGF_extracell | 1.26e-02 | 60 | 53 | 2 | IPR013111 | |
| Domain | EGF_2 | 1.26e-02 | 60 | 53 | 2 | PF07974 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.26e-02 | 685 | 53 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.32e-02 | 691 | 53 | 6 | PS50262 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 5.23e-09 | 23 | 41 | 5 | M47537 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 5.23e-09 | 23 | 41 | 5 | M47720 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.02e-08 | 26 | 41 | 5 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.02e-08 | 26 | 41 | 5 | M47719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.51e-08 | 28 | 41 | 5 | M47655 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 2.18e-08 | 30 | 41 | 5 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.18e-08 | 30 | 41 | 5 | M47718 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.83e-06 | 31 | 41 | 4 | MM15691 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.25e-06 | 74 | 41 | 5 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.25e-06 | 74 | 41 | 5 | M16376 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.57e-06 | 76 | 41 | 5 | M27219 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.79e-06 | 37 | 41 | 4 | MM15067 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 3.97e-06 | 83 | 41 | 5 | M8728 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 4.22e-06 | 84 | 41 | 5 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.47e-06 | 85 | 41 | 5 | M16441 | |
| Pathway | REACTOME_EICOSANOIDS | 4.93e-06 | 12 | 41 | 3 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 4.93e-06 | 12 | 41 | 3 | MM14845 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 5.93e-06 | 90 | 41 | 5 | M835 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 8.13e-06 | 14 | 41 | 3 | MM15842 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.00e-05 | 47 | 41 | 4 | MM14925 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.01e-05 | 15 | 41 | 3 | M27126 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.09e-05 | 102 | 41 | 5 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 1.09e-05 | 102 | 41 | 5 | MM15830 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 1.51e-05 | 52 | 41 | 4 | M5785 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.81e-05 | 18 | 41 | 3 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.81e-05 | 18 | 41 | 3 | MM14841 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 2.51e-05 | 121 | 41 | 5 | M39823 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 5.02e-05 | 25 | 41 | 3 | MM14858 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 6.36e-05 | 27 | 41 | 3 | M27217 | |
| Pathway | WP_GPCRS_ODORANT | 8.72e-05 | 157 | 41 | 5 | MM15872 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 1.17e-04 | 33 | 41 | 3 | MM15918 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.17e-04 | 33 | 41 | 3 | MM15963 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.66e-04 | 37 | 41 | 3 | M27134 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.94e-04 | 39 | 41 | 3 | M793 | |
| Pathway | WP_FOCAL_ADHESION | 1.98e-04 | 187 | 41 | 5 | MM15913 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.13e-04 | 190 | 41 | 5 | MM15687 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.14e-04 | 430 | 41 | 7 | MM15160 | |
| Pathway | WP_FOCAL_ADHESION | 2.64e-04 | 199 | 41 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.64e-04 | 199 | 41 | 5 | M7253 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.78e-04 | 44 | 41 | 3 | M26969 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 3.39e-04 | 47 | 41 | 3 | M42524 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.39e-04 | 47 | 41 | 3 | M646 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 3.62e-04 | 213 | 41 | 5 | M18306 | |
| Pathway | PID_ARF6_TRAFFICKING_PATHWAY | 3.83e-04 | 49 | 41 | 3 | M67 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.63e-04 | 59 | 41 | 3 | M27218 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 7.31e-04 | 61 | 41 | 3 | MM14861 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 7.35e-04 | 14 | 41 | 2 | MM14923 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 7.67e-04 | 62 | 41 | 3 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 8.41e-04 | 64 | 41 | 3 | M5650 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.64e-04 | 258 | 41 | 5 | MM14572 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 9.20e-04 | 66 | 41 | 3 | MM14839 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 9.20e-04 | 66 | 41 | 3 | M18 | |
| Pathway | WP_GPCRS_NONODORANT | 9.91e-04 | 266 | 41 | 5 | MM15843 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.39e-03 | 76 | 41 | 3 | MM14867 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 1.43e-03 | 289 | 41 | 5 | MM15057 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.67e-03 | 21 | 41 | 2 | M27137 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.69e-03 | 300 | 41 | 5 | M610 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.74e-03 | 302 | 41 | 5 | M39719 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.06e-03 | 463 | 41 | 6 | M507 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 2.37e-03 | 646 | 41 | 7 | MM14962 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.43e-03 | 326 | 41 | 5 | MM15917 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.55e-03 | 94 | 41 | 3 | M1041 | |
| Pathway | REACTOME_FERTILIZATION | 2.57e-03 | 26 | 41 | 2 | M26922 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.87e-03 | 339 | 41 | 5 | M39736 | |
| Pathway | PID_CXCR4_PATHWAY | 3.04e-03 | 100 | 41 | 3 | M124 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.39e-03 | 104 | 41 | 3 | M738 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.41e-03 | 30 | 41 | 2 | M27216 | |
| Pathway | REACTOME_REPRODUCTION | 3.41e-03 | 30 | 41 | 2 | MM17211 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.49e-03 | 105 | 41 | 3 | MM14842 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.87e-03 | 32 | 41 | 2 | MM14924 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.87e-03 | 32 | 41 | 2 | MM14854 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 5.43e-03 | 38 | 41 | 2 | MM14874 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.71e-03 | 39 | 41 | 2 | MM14601 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 6.60e-03 | 42 | 41 | 2 | M174 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 7.02e-03 | 135 | 41 | 3 | MM14781 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 8.21e-03 | 47 | 41 | 2 | M39829 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 8.55e-03 | 620 | 41 | 6 | MM15193 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 8.55e-03 | 48 | 41 | 2 | MM15902 | |
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 4.26e-11 | 16 | 57 | 5 | 12904471 | |
| Pubmed | Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence. | 3.25e-10 | 23 | 57 | 5 | 23152823 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 7.76e-10 | 27 | 57 | 5 | 31541017 | |
| Pubmed | 1.92e-09 | 32 | 57 | 5 | 23154389 | ||
| Pubmed | 4.58e-09 | 13 | 57 | 4 | 15938754 | ||
| Pubmed | 3.80e-08 | 21 | 57 | 4 | 10761934 | ||
| Pubmed | Evolutionary relationships of the Tas2r receptor gene families in mouse and human. | 4.64e-08 | 22 | 57 | 4 | 12734386 | |
| Pubmed | The molecular receptive ranges of human TAS2R bitter taste receptors. | 5.61e-08 | 23 | 57 | 4 | 20022913 | |
| Pubmed | 7.99e-08 | 25 | 57 | 4 | 12139982 | ||
| Pubmed | 8.32e-08 | 6 | 57 | 3 | 9068972 | ||
| Pubmed | Molecular mechanisms of bitter and sweet taste transduction. | 9.43e-08 | 26 | 57 | 4 | 11696554 | |
| Pubmed | 1.11e-07 | 27 | 57 | 4 | 12581520 | ||
| Pubmed | Mapping of QTLs for oral alcohol self-administration in B6.C and B6.I quasi-congenic RQI strains. | 1.72e-07 | 30 | 57 | 4 | 17273929 | |
| Pubmed | Adaptive diversification of bitter taste receptor genes in Mammalian evolution. | 1.72e-07 | 30 | 57 | 4 | 12679530 | |
| Pubmed | Developmental regulation of integrin expression at the time of implantation in the mouse embryo. | 2.32e-07 | 8 | 57 | 3 | 8306881 | |
| Pubmed | 9.09e-07 | 12 | 57 | 3 | 19693543 | ||
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 9.09e-07 | 12 | 57 | 3 | 12379855 | |
| Pubmed | 1.18e-06 | 13 | 57 | 3 | 20563599 | ||
| Pubmed | Genetic nomenclature for loci controlling surface antigens of mouse hemopoietic cells. | 1.79e-06 | 53 | 57 | 4 | 1431091 | |
| Pubmed | [Association of the integrin gene polymorphisms with ischemic stroke and plasma lipid levels]. | 2.64e-06 | 2 | 57 | 2 | 19350519 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17702579 | ||
| Pubmed | Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk. | 2.64e-06 | 2 | 57 | 2 | 16317580 | |
| Pubmed | Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk. | 2.64e-06 | 2 | 57 | 2 | 18836731 | |
| Pubmed | Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. | 2.64e-06 | 2 | 57 | 2 | 11786903 | |
| Pubmed | Expression and physiological function of CYP4F subfamily in human eosinophils. | 2.64e-06 | 2 | 57 | 2 | 17980168 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 11812069 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 9339637 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16380674 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17074516 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16112640 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19197137 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19235843 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 25643034 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15537898 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 27405521 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19635510 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 21044892 | ||
| Pubmed | Integrin αII b tail distal of GFFKR participates in inside-out αII b β3 activation. | 2.64e-06 | 2 | 57 | 2 | 24837519 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 16288021 | ||
| Pubmed | [New perspectives on the role of αIIbβ3 integrin in defective megakaryopoiesis]. | 2.64e-06 | 2 | 57 | 2 | 27011248 | |
| Pubmed | Idiopathic sudden sensorineural hearing loss: classic cardiovascular and new genetic risk factors. | 2.64e-06 | 2 | 57 | 2 | 22948415 | |
| Pubmed | The impact of platelet glycoprotein IIIa and Ia polymorphisms in cardiovascular thrombotic disease. | 2.64e-06 | 2 | 57 | 2 | 12690916 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 21508388 | ||
| Pubmed | PREB TMEM161A ATP13A1 SLC19A1 DHRS7 ITGA2 SAYSD1 ITGB5 GPAT4 STX12 | 3.03e-06 | 952 | 57 | 10 | 38569033 | |
| Pubmed | TMEM161A DHRS7 CST9L CD300LB CLMP CYP4F12 ITGA7 SLC44A4 GPAT4 IL17RB | 4.10e-06 | 985 | 57 | 10 | 12975309 | |
| Pubmed | 4.66e-06 | 20 | 57 | 3 | 22687584 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 28815933 | ||
| Pubmed | Targeting ανβ3 and ανβ5 inhibits photon-induced hypermigration of malignant glioma cells. | 7.91e-06 | 3 | 57 | 2 | 21978494 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15847651 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15355504 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15355503 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18997092 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15546585 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 29461866 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 20076847 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 28388872 | ||
| Pubmed | Mfge8 regulates enterocyte lipid storage by promoting enterocyte triglyceride hydrolase activity. | 7.91e-06 | 3 | 57 | 2 | 27812539 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 17127487 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16467530 | ||
| Pubmed | Gene frequencies of human platelet antigens 1-5 in indigenous Australians in Western Australia. | 7.91e-06 | 3 | 57 | 2 | 12071877 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 26758421 | ||
| Pubmed | Gene frequencies of human platelet alloantigens in Bahraini Arabs. | 7.91e-06 | 3 | 57 | 2 | 17160992 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15227729 | ||
| Pubmed | [Occurrence of plasmic and platelet prothrombotic polymorphisms in women in childbirth]. | 7.91e-06 | 3 | 57 | 2 | 16875034 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 12499711 | ||
| Pubmed | Requirement of integrin β3 for iron transportation during enamel formation. | 7.91e-06 | 3 | 57 | 2 | 23064962 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 17196570 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16421008 | ||
| Pubmed | HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. | 7.91e-06 | 3 | 57 | 2 | 15730528 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18641368 | ||
| Pubmed | [Conformational regulation of integrin activation in drug discovery]. | 7.91e-06 | 3 | 57 | 2 | 24850451 | |
| Pubmed | Role of five platelet membrane glycoprotein polymorphisms in branch retinal vein occlusion. | 7.91e-06 | 3 | 57 | 2 | 16905953 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 12073410 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18985734 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 22074485 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 26514956 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 32998468 | ||
| Pubmed | Gene frequencies of human platelet antigens in the Macedonian population. | 7.91e-06 | 3 | 57 | 2 | 16573563 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 15456946 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 24979111 | ||
| Pubmed | Lineage-specific loss of function of bitter taste receptor genes in humans and nonhuman primates. | 1.33e-05 | 28 | 57 | 3 | 15744053 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 22015659 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 15978110 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 7525578 | ||
| Pubmed | αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer. | 1.58e-05 | 4 | 57 | 2 | 25150423 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 22665481 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 28358707 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 17346829 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 1.58e-05 | 4 | 57 | 2 | 11185557 | |
| Pubmed | Expression pattern of alphavbeta3 and alphavbeta5 integrin mRNA in mouse fetal gonads. | 1.58e-05 | 4 | 57 | 2 | 16571912 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 12055214 | ||
| Pubmed | Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction. | 1.58e-05 | 4 | 57 | 2 | 24639195 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 7682219 | ||
| Pubmed | Human platelet antigens polymorphisms and susceptibility of thrombosis in hemodialysis patients. | 1.58e-05 | 4 | 57 | 2 | 18638089 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 19702628 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 17728329 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 24959655 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 19255147 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 9849968 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 19815553 | ||
| Interaction | BRICD5 interactions | 5.56e-07 | 194 | 51 | 7 | int:BRICD5 | |
| Interaction | ADAM21 interactions | 2.07e-05 | 64 | 51 | 4 | int:ADAM21 | |
| Interaction | ATP2A3 interactions | 2.55e-05 | 232 | 51 | 6 | int:ATP2A3 | |
| Interaction | CDHR4 interactions | 2.63e-05 | 68 | 51 | 4 | int:CDHR4 | |
| Interaction | SEC62 interactions | 3.68e-05 | 506 | 51 | 8 | int:SEC62 | |
| Interaction | BTNL2 interactions | 4.45e-05 | 155 | 51 | 5 | int:BTNL2 | |
| Interaction | HLA-F interactions | 6.63e-05 | 86 | 51 | 4 | int:HLA-F | |
| Interaction | CDH26 interactions | 9.36e-05 | 6 | 51 | 2 | int:CDH26 | |
| Interaction | DEFB109B interactions | 1.21e-04 | 38 | 51 | 3 | int:DEFB109B | |
| Interaction | CD300LB interactions | 1.31e-04 | 7 | 51 | 2 | int:CD300LB | |
| Interaction | SLC18B1 interactions | 1.74e-04 | 8 | 51 | 2 | int:SLC18B1 | |
| Interaction | CYP4F8 interactions | 1.74e-04 | 8 | 51 | 2 | int:CYP4F8 | |
| Interaction | STAB2 interactions | 2.23e-04 | 9 | 51 | 2 | int:STAB2 | |
| Interaction | BTNL8 interactions | 2.29e-04 | 47 | 51 | 3 | int:BTNL8 | |
| Interaction | TRAV20 interactions | 2.44e-04 | 48 | 51 | 3 | int:TRAV20 | |
| Interaction | CD160 interactions | 2.44e-04 | 48 | 51 | 3 | int:CD160 | |
| Interaction | CANX interactions | PREB SLC11A2 ATP13A1 ADAM21 SLC19A1 BRICD5 F2RL1 ITGB5 GPAT4 IL17RB STX12 | 2.58e-04 | 1261 | 51 | 11 | int:CANX |
| Interaction | ZDHHC12 interactions | 2.65e-04 | 123 | 51 | 4 | int:ZDHHC12 | |
| Interaction | REEP5 interactions | 3.35e-04 | 371 | 51 | 6 | int:REEP5 | |
| Interaction | SLC32A1 interactions | 3.40e-04 | 11 | 51 | 2 | int:SLC32A1 | |
| Interaction | TRGV3 interactions | 3.65e-04 | 55 | 51 | 3 | int:TRGV3 | |
| Interaction | ASIC4 interactions | 3.67e-04 | 134 | 51 | 4 | int:ASIC4 | |
| Interaction | TMEM216 interactions | 3.87e-04 | 246 | 51 | 5 | int:TMEM216 | |
| Interaction | LYPD1 interactions | 4.27e-04 | 58 | 51 | 3 | int:LYPD1 | |
| Cytoband | 1p35.3 | 8.00e-04 | 34 | 56 | 2 | 1p35.3 | |
| Cytoband | 12p13.2 | 1.40e-03 | 45 | 56 | 2 | 12p13.2 | |
| Cytoband | 14q11.2 | 1.41e-03 | 180 | 56 | 3 | 14q11.2 | |
| Cytoband | 19p13.1 | 1.59e-03 | 48 | 56 | 2 | 19p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.86e-03 | 797 | 56 | 5 | chr19p13 | |
| Cytoband | 12q13 | 3.44e-03 | 71 | 56 | 2 | 12q13 | |
| Cytoband | 19p13.11 | 3.63e-03 | 73 | 56 | 2 | 19p13.11 | |
| GeneFamily | Taste 2 receptors | 2.58e-06 | 39 | 45 | 4 | 1162 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 1.15e-05 | 18 | 45 | 3 | 1160 | |
| GeneFamily | Cytochrome P450 family 4 | 9.71e-05 | 36 | 45 | 3 | 1003 | |
| GeneFamily | CD molecules|Integrin beta subunits | 2.16e-04 | 9 | 45 | 2 | 1159 | |
| GeneFamily | Ribonuclease A family | 4.64e-04 | 13 | 45 | 2 | 723 | |
| GeneFamily | Solute carriers | 2.89e-03 | 395 | 45 | 5 | 752 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 7.74e-03 | 163 | 45 | 3 | 590 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.64e-02 | 394 | 45 | 4 | 471 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.BM, B220neg CD3neg CD115+ Ly-6C/Glo CD43+, Bone marrow, avg-3 | 2.56e-05 | 74 | 49 | 4 | GSM854332_100 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.40e-08 | 169 | 55 | 6 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.63e-07 | 198 | 55 | 6 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.63e-07 | 198 | 55 | 6 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.83e-06 | 191 | 55 | 5 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.93e-06 | 192 | 55 | 5 | 7e7383093efaadceadd4d1f900c2d39cd690102e | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-06 | 195 | 55 | 5 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-06 | 195 | 55 | 5 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.24e-06 | 195 | 55 | 5 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.57e-06 | 198 | 55 | 5 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.68e-06 | 199 | 55 | 5 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-06 | 199 | 55 | 5 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-06 | 199 | 55 | 5 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.68e-06 | 199 | 55 | 5 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 4.79e-06 | 200 | 55 | 5 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | mLN-(6)_Macrophage-(61)_LYVE1_Macrophage|mLN / shred on region, Cell_type, and subtype | 4.79e-06 | 200 | 55 | 5 | a20f5ec61d492d8a2adf695ec304b5d57296aa8f | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|mLN / Region, Cell class and subclass | 4.79e-06 | 200 | 55 | 5 | 89cf739a3c2f5d30e547404f2f2ec6500cd1d65d | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 4.79e-06 | 200 | 55 | 5 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 4.79e-06 | 200 | 55 | 5 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 4.79e-06 | 200 | 55 | 5 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 5.28e-06 | 204 | 55 | 5 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 5.54e-06 | 206 | 55 | 5 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.45e-05 | 149 | 55 | 4 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.45e-05 | 149 | 55 | 4 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.77e-05 | 170 | 55 | 4 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | Monocytes-IFN-activated_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.91e-05 | 171 | 55 | 4 | df1b631618839bee4a18a2ba9c730321e5015f36 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-05 | 171 | 55 | 4 | 7c8304573b892ef9ea4e048cba9ea9fbab848dcd | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.18e-05 | 173 | 55 | 4 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.18e-05 | 173 | 55 | 4 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-05 | 181 | 55 | 4 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | megakaryocytic|World / Lineage and Cell class | 7.85e-05 | 184 | 55 | 4 | b1c630ca2189d9d49402a5621b57618976fbea5c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.01e-05 | 185 | 55 | 4 | 9bff336510c80cd762b4e41b4570475033e709ca | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.01e-05 | 185 | 55 | 4 | 452d49c7835a4d55e41caefa44dac5cab30e7ced | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.01e-05 | 185 | 55 | 4 | 53f5136ee1bd101dd5ac8a2c9e63b0c3b987657e | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.01e-05 | 185 | 55 | 4 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.01e-05 | 185 | 55 | 4 | 67ac5c2bacdbdcb40ee65c44da55b3f597b410ee | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.35e-05 | 187 | 55 | 4 | bde6b90955423eab6a91a0abe75d0a95a1f5330a | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.35e-05 | 187 | 55 | 4 | 39b99f46b723f7f3c44880d7fe8642cbad558b8a | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 8.52e-05 | 188 | 55 | 4 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 8.52e-05 | 188 | 55 | 4 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 8.52e-05 | 188 | 55 | 4 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.70e-05 | 189 | 55 | 4 | 3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da | |
| ToppCell | mild-Others|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.88e-05 | 190 | 55 | 4 | 782dc1b612ac1faad7cc2781bfda92a079830d38 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.88e-05 | 190 | 55 | 4 | 081b7bc07b6e5685e8a91b9ae6c1141623723700 | |
| ToppCell | 390C-Myeloid-Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.88e-05 | 190 | 55 | 4 | f933d971f092c4e56e9f670a9205b688c8b1ca28 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.06e-05 | 191 | 55 | 4 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage2_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 191 | 55 | 4 | 09dfad8e1fcaaf94775134796b99e4e3fbb9bf40 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.06e-05 | 191 | 55 | 4 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | mild-Others-Megakaryocytes|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.06e-05 | 191 | 55 | 4 | 0b36223bd7f5758cc37194da6cc252f613bc3c97 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 9.43e-05 | 193 | 55 | 4 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.43e-05 | 193 | 55 | 4 | 2d0dd2671ff27b922eb316f1ed0140353536ef30 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.62e-05 | 194 | 55 | 4 | ef30baa19b7aa97b61dea916fc2e0f5cf49848d6 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.62e-05 | 194 | 55 | 4 | c53478057674d70b79df8a3f476d15dea1925753 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.62e-05 | 194 | 55 | 4 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.62e-05 | 194 | 55 | 4 | 846b4170544cdf58b536fb7a5fd34b79b0b17993 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.62e-05 | 194 | 55 | 4 | 2ab3f75b795a0ee4fe0f8eeba33093fcc77935f5 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.62e-05 | 194 | 55 | 4 | a062100ea6cd512a108f9036c259e0cd0f458563 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.62e-05 | 194 | 55 | 4 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.62e-05 | 194 | 55 | 4 | 8805c90e4284a81a6c8078f2d2417ae77b4e5c63 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.62e-05 | 194 | 55 | 4 | 86d52467b05a0018517377c9c441245501f71d91 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.62e-05 | 194 | 55 | 4 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.62e-05 | 194 | 55 | 4 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a8.Fezf2-Slc17a8_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.71e-05 | 72 | 55 | 3 | e3f4d1df43cc41b0424f27485a00ddca9e905f95 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.82e-05 | 195 | 55 | 4 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.82e-05 | 195 | 55 | 4 | 518cc3baeb7cf2ad068692cbe85fd75be67f1872 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM5|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 9.82e-05 | 195 | 55 | 4 | 6d768454ed630e586431535400507074eea76dd1 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.82e-05 | 195 | 55 | 4 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.00e-04 | 196 | 55 | 4 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 1.00e-04 | 196 | 55 | 4 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.00e-04 | 196 | 55 | 4 | ce3709adbde7559b40c964888935914f66003247 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.00e-04 | 196 | 55 | 4 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | COVID-19_Severe|World / disease group, cell group and cell class | 1.00e-04 | 196 | 55 | 4 | 3bedf60f662b373ad9d0f07d4da9f11864af3a74 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-04 | 196 | 55 | 4 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 1.02e-04 | 197 | 55 | 4 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-04 | 197 | 55 | 4 | e3349a381723393cd255f202afedd0c99037939b | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 197 | 55 | 4 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 197 | 55 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_macrophage-macrophage|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-04 | 197 | 55 | 4 | e567886d69c6ea8dec87019c2ebc593793cb3107 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 198 | 55 | 4 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | distal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 199 | 55 | 4 | 8f0a72a95d0310ef2324c6975495c294b5a47cc8 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 1.06e-04 | 199 | 55 | 4 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 1.06e-04 | 199 | 55 | 4 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 199 | 55 | 4 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.06e-04 | 199 | 55 | 4 | fb63885273d906a85fef178d859d20a311eb8a72 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | 1.06e-04 | 199 | 55 | 4 | facf79c256db5ae57bdb613e86ec90616a6f67ca | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 1.06e-04 | 199 | 55 | 4 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.06e-04 | 199 | 55 | 4 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 1.06e-04 | 199 | 55 | 4 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 199 | 55 | 4 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 1.08e-04 | 200 | 55 | 4 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 1.08e-04 | 200 | 55 | 4 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 1.08e-04 | 200 | 55 | 4 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 1.08e-04 | 200 | 55 | 4 | bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60 | |
| ToppCell | Caecum-Macrophage-Macrophage|Caecum / Region, Cell class and subclass | 1.08e-04 | 200 | 55 | 4 | 99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.08e-04 | 200 | 55 | 4 | 670ef1e68be0d2c6ea20ab4dea1d051a3cc89799 | |
| ToppCell | Transverse-Macrophage|Transverse / Region, Cell class and subclass | 1.08e-04 | 200 | 55 | 4 | 1920605e5811938814d02b971069a4506868db5f | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 1.08e-04 | 200 | 55 | 4 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | Sigmoid-(6)_Macrophage-(60)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 1.08e-04 | 200 | 55 | 4 | ad84a83a5a1893f7b053d39eddeca851463a8ff0 | |
| ToppCell | Caecum-(6)_Macrophage-(60)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.08e-04 | 200 | 55 | 4 | 67b6cdeb07ffc5c9af7a3e738dd31256cf391e98 | |
| ToppCell | Sigmoid-Macrophage-LYVE1_Macrophage|Sigmoid / Region, Cell class and subclass | 1.08e-04 | 200 | 55 | 4 | 851a1b372ddbec522829069e69ed36a1f4832131 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 55 | 4 | ce969c958a31145bbfe315a9a865d7900ecc9549 | |
| Computational | Genes in the cancer module 412. | 3.54e-06 | 13 | 26 | 3 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 6.89e-06 | 16 | 26 | 3 | MODULE_275 | |
| Computational | Genes in the cancer module 424. | 8.41e-04 | 18 | 26 | 2 | MODULE_424 | |
| Computational | Genes in the cancer module 478. | 9.38e-04 | 19 | 26 | 2 | MODULE_478 | |
| Computational | Genes in the cancer module 243. | 9.46e-04 | 81 | 26 | 3 | MODULE_243 | |
| Drug | indole-3-acetyl-l-valine | 5.05e-07 | 65 | 55 | 5 | CID000446641 | |
| Drug | N-methylformamide | 5.46e-07 | 66 | 55 | 5 | CID000031254 | |
| Drug | azo analog I | 3.75e-06 | 13 | 55 | 3 | CID006438575 | |
| Drug | saccharin | 8.81e-06 | 54 | 55 | 4 | CID000005143 | |
| Drug | calcium carbonate | 9.40e-06 | 203 | 55 | 6 | CID000010112 | |
| Drug | Cilengitide | 1.72e-05 | 3 | 55 | 2 | ctd:C422910 | |
| Drug | trypanothione disulfide | 2.22e-05 | 140 | 55 | 5 | CID000115098 | |
| Drug | ebastine | 2.95e-05 | 25 | 55 | 3 | CID000003191 | |
| Drug | NAP-taurine | 3.43e-05 | 4 | 55 | 2 | CID002735433 | |
| Disease | Glanzmann's thrombasthenia (is_implicated_in) | 9.49e-06 | 3 | 53 | 2 | DOID:2219 (is_implicated_in) | |
| Disease | thrombocytopenia (is_implicated_in) | 1.55e-05 | 27 | 53 | 3 | DOID:1588 (is_implicated_in) | |
| Disease | Neonatal Alloimmune Thrombocytopenia | 4.73e-05 | 6 | 53 | 2 | C3853779 | |
| Disease | FNAITP | 4.73e-05 | 6 | 53 | 2 | C3854603 | |
| Disease | thrombosis (is_implicated_in) | 3.27e-04 | 15 | 53 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 3.27e-04 | 15 | 53 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | Gliosis | 4.23e-04 | 17 | 53 | 2 | C0017639 | |
| Disease | Astrocytosis | 4.23e-04 | 17 | 53 | 2 | C3887640 | |
| Disease | malaria (is_implicated_in) | 8.52e-04 | 24 | 53 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | migraine disorder, diastolic blood pressure | 9.25e-04 | 25 | 53 | 2 | EFO_0006336, MONDO_0005277 | |
| Disease | Thrombocytopenia | 1.25e-03 | 29 | 53 | 2 | C0040034 | |
| Disease | cancer (implicated_via_orthology) | 1.37e-03 | 268 | 53 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | end stage renal disease (is_implicated_in) | 2.48e-03 | 41 | 53 | 2 | DOID:783 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IVLTILLCEVLLGWL | 131 | Q7RTX7 | |
| GWRAVSLLLLLLLLV | 26 | Q6PL45 | |
| RVTLLLLWLGVFLSI | 11 | Q9UKJ8 | |
| WSLAVSLLAIIGLLL | 1136 | Q9HD20 | |
| LWLLQPLTVLLLLAS | 16 | P12318 | |
| LLLISATWLLGLLAV | 2661 | Q9NYQ6 | |
| LLWLLVLCALLLLLV | 6 | Q9Y394 | |
| WLLNGLLLTLQLLHV | 311 | Q8N5B7 | |
| LLTVGLLVLLEWQLN | 1001 | A7MBM2 | |
| LLTLLIIWTLLGNVL | 46 | P21918 | |
| LPLLLLSLLVATWVL | 291 | Q9NRM6 | |
| WILLLATLVGLLLQR | 106 | P49281 | |
| ILTQLGNLLILITVW | 36 | Q8NGC4 | |
| AGILLLLALVAILWK | 1141 | P17301 | |
| ILLVGLALLAIWKLL | 731 | P18084 | |
| LGLLVLAILTLALWK | 1021 | P53708 | |
| AIGISLAIWLLILLV | 191 | P55085 | |
| LWISGILAILRVLIS | 1671 | P42858 | |
| ISLRLTVLWGLGVLI | 156 | Q86UL3 | |
| WLLTLRLLLGALLVW | 341 | H7C350 | |
| LLLVVGASWLLARIL | 21 | P98187 | |
| LLLLVVGSWLLARIL | 21 | Q9HCS2 | |
| ELLTLLLSLLPLVWK | 71 | Q99698 | |
| LLLLLVLLLWLLQVS | 11 | Q8IXH8 | |
| LLIGLAALLIWKLLI | 731 | P05106 | |
| WILVALGVALVLSLL | 231 | Q53GD3 | |
| AGLLVLALLVLLLWK | 1091 | Q13683 | |
| LLLLVGASWLLARIL | 21 | Q08477 | |
| SWALLLLLLGSQILL | 11 | Q9H4G1 | |
| SNSGLLVIIWFLLLL | 201 | Q15615 | |
| QRITWKGLLLTALLL | 11 | Q16557 | |
| LSNLTILWLKLLLNI | 2071 | Q86VV8 | |
| KLLIILAISRIGLIW | 46 | Q9NYV9 | |
| LAVSRVGLLWVLLLN | 51 | P59538 | |
| LAVSRVGLLWVLLLN | 51 | P59537 | |
| LAVSRVGLLWVLLLN | 51 | P59539 | |
| LWLLVVLCLLRLAVT | 316 | Q9NX61 | |
| QLWLLVLILVVSGLS | 331 | Q6NT16 | |
| ALLVVILLARLILWS | 16 | A0A286YFK9 | |
| VLLWALSLLLSILEG | 151 | Q96LB1 | |
| ILNEGLSTILVLSWL | 6 | Q9HBY0 | |
| LLLVLILLVLGWVQP | 11 | P07998 | |
| ILLILVTAILWLKGS | 161 | A8K4G0 | |
| IVAGALLIFLLVWLL | 241 | Q9H6B4 | |
| ILKLLSWIILSNLFL | 36 | Q8N8G6 | |
| VWLLLLLCVGLIIVT | 391 | Q9HCU5 | |
| LLLLLLGLWVAEVLV | 11 | Q8TDE3 | |
| SILLLLGSFILLNVW | 26 | A0A1B0GUW6 | |
| VTLFKLLLLWLVLSL | 36 | P57738 | |
| LLLLWLVLSLLGIQL | 41 | P57738 | |
| LVLSVIILILGLIIW | 256 | Q86Y82 | |
| LLLQGLSFVSVWLLL | 96 | P41440 | |
| LSLSVALLWQSLILL | 221 | Q8N816 | |
| QLLWVLGLLVGLLLL | 1641 | Q9BZZ2 | |
| ITFLKVLLWLVLLGL | 101 | Q9NPB0 | |
| LISLAIWVLVTLELL | 141 | Q9BXA5 | |
| ILKVLLWLLAILTGL | 66 | Q9H0C3 | |
| TFILLLTLTILTIWL | 76 | Q96T83 |